scispace - formally typeset
T

Tian Xia

Researcher at Huazhong University of Science and Technology

Publications -  51
Citations -  3569

Tian Xia is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Medicine & G protein-coupled receptor. The author has an hindex of 13, co-authored 42 publications receiving 2216 citations. Previous affiliations of Tian Xia include University of Minnesota & Iowa State University.

Papers
More filters
Journal ArticleDOI

Pan-cancer analysis of whole genomes

Peter J. Campbell, +1332 more
- 06 Feb 2020 - 
TL;DR: The flagship paper of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium describes the generation of the integrative analyses of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types, the structures for international data sharing and standardized analyses, and the main scientific findings from across the consortium studies.
Journal ArticleDOI

A global genetic interaction network maps a wiring diagram of cellular function

TL;DR: A global genetic interaction network highlights the functional organization of a cell and provides a resource for predicting gene and pathway function and how coherent sets of negative or positive genetic interactions connect protein complex and pathways to map a functional wiring diagram of the cell.
Journal ArticleDOI

Endogenous DNA replication stress results in expansion of dNTP pools and a mutator phenotype.

TL;DR: The data point to a vicious circle in which mutations in gatekeeper genes give rise to genomic instability during S phase, inducing expansion of the dNTP pool, which in turn results in high levels of spontaneous mutagenesis.
Journal ArticleDOI

Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model

TL;DR: Findings show that GEP may be used to document bortezomib resistance in myeloma cells and predict individual sensitivity to other drug classes, and suggest that resistance to one drug class reprograms resistant clones for increased sensitivity to a distinct class of drugs.